Matches 1 - 50 out of 378 1 2 3 4 5 6 7 8 >
Match Document Document Title
7598423 Potentiators of glutamate receptors  
This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating...
7579366 Epothilone derivatives and their synthesis and use  
The invention relates to epothilone analog represented by the formula I wherein (i) R 2 is absent or oxygen; “a” can be either a single or double bond; “b” can be either absent or a...
7579355 Inhibitors of Akt activity  
The present invention is directed to compounds which contain a substituted pyridine moeity which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to...
7524957 Compounds effecting glucokinase  
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R 1 , R 2 , R 3 , n and m are as described in the specification, in the preparation of a...
7427635 Substituted hydantoins  
The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment...
7423156 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity  
This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.
7423055 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases  
The present invention relates to novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain...
7414067 Ophthalmic compositions for treating ocular hypertension  
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in...
7408069 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives  
A method for preparing a compound of the structure I,
7384968 Thiazole-amine compounds for the treatment of neurodegenerative disorders  
The present invention relates to compounds of the Formula I wherein R 1 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined. Compounds of the Formula I have activity inhibiting production of...
7384928 Broad spectrum cephem compounds  
A compound of the formula: (wherein, T is S, SO or O; X is halogen, CN, carbamoyl optionally substituted with lower alkyl, lower alkyl, lower alkoxy, or lower alkylthio; A is substituted lower...
7358267 Bis-aryl thiazole derivatives  
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by an uncoupling protein. In particular, the compounds of the...
7342117 α-form or β-form crystal of acetanilide derivative  
To provide novel crystals useful as an ingredient for the production of a diabetes remedy. The invention is concerned with α-form crystal and β-form crystal of...
7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity  
The present application describes modulators of chemokine receptors of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic...
7253197 Aminothiazole derivatives  
Compounds of formula I as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 4 have the significance given in the specification, and the compounds, salts and...
7250508 Cefdinir intermediate  
7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetami do]-3-vinyl-cephem-4-carboxylic acid of formula I in the form of a crystalline salt and use thereof, e.g. in the preparation of pure...
7250431 Thiazole derivatives  
Thiazole derivatives of formula I are provided as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 5 , a and b have the significance given in the specification....
7244278 Agent and method for oxidative coloring of keratin fibers  
The object of the present invention is a ready-to-use agent for coloring keratin fibers containing (i) at least one heterocyclic hydrazone derivative of formula (I), (ii) at least one aromatic...
7179827 Thiazoles and methods of their use  
This invention concerns novel thiazole compounds. Methods of using these compounds for the treatment, prevention and management of various diseases or disorders, as well as pharmaceutical...
7173137 Epothilone analogs  
Epothilone A, epothilone B, analogs of epothilone and libraries of epothilone analogs are synthesized. Epothilone A and B are known anticancers agents that derive their anticancer activity by the...
7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases  
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula or its pharmaceutically acceptable salt or ester, wherein the substituents...
7163952 Azole compound and medicinal use thereof  
The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is —COOR 7 , —X 1 -A 1 -COOR 7 (R 7 is H, alkyl) or tetrazolyl; R 1 , R 2 , R 3 ...
7145017 Preparation of Aztreonam  
The invention relates to a process for the synthesis of Aztreonam. Specifically, the process entails hydrolyzing...
7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1  
The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the...
7105564 Pharmaceutical composition comprising a dual antagonist against PGD2/TXA2 receptors having a [2.2.1] or [3.1.1] bicyclic skeleton  
The present invention provides novel compounds having a dual antagonistic activity against thromboxane A2 receptor and prostaglandin D 2 receptor and pharmaceutical compositions comprising them. ...
7091228 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity  
This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.
7074794 Proline derivatives and the use thereof as drugs  
The present invention aims at providing compounds having therapeutic effects due to a DPP-IV inhibitory action, and satisfactory as pharmaceutical products. The present inventors have found that...
6984735 Process for making an aldehyde  
A process for making an aromatic aldehyde in which a sulfoxide is reacted with a dihalogenated aromatic compound in the absence of an effective amount of an activating reagent. The aldehyde may...
6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use  
2-(S)-hydroxymutilin carbamate derivatives of formula (I), in which R 1 is a 5- or 6-membered optionally substituted heteroaryl group; and R 2 is vinyl or ethyl, are useful in the treatment of...
6967212 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method  
Compounds are provided which have the structure wherein Q is C or N; R 2a , R 2b , R 2c , X 1 to X 7 , R 1 , R 2 , R 3 , R 3a , R 4 , A, Y, m, and n are as defined herein, which compounds are...
6960664 Aza hydroxylated ethyl amine compounds  
Disclosed are compounds of formula: and pharmaceutically acceptable salts and esters thereof, useful in treating and/or preventing Alzheimer's disease and other similar diseases, wherein R N ,...
6924300 Oxyiminoalkanoic acid derivatives  
To provide a novel oxyiminoalkanoic acid derivative which has excellent hypoglycemic and hypolipidemic actions and which is used for the prevention or treatment of diabetes mellitus, hyperlipemia,...
6921770 2-Phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same  
2-phenyliminothiazolines of the following formula I, their salts, their preparation method and their use for treating rice blast. The phenyliminothiazolines and their salts of the present invention...
6878827 Process for producing anhydride of aminothiazole derivative  
This invention provides a novel industrial process for preparation of an anhydride of 2-(2-aminothiazole-4-yl)-2-hydroxy compound.
6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists  
The present invention relates to novel substituted benzofurans and benzothiophenes compounds that are antagonists of alpha V (αv) integrins, for example α v β 3 and α v β 5 integrins, their...
6818775 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity  
Compounds of the formula where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.
6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds  
Substituted tetracycline compounds, methods of synthesis, and methods of use are discussed. Tetracyclines useful for treating tetracycline related disorders are also discussed. Intermediates useful...
6797723 Heterocycle substituted diphenyl leukotriene antagonists  
The invention relates to novel heterocycle substituted diphenyl leukotriene B 4 (LTB 4 ) antagonists, to compositions containing such compounds, and to methods of using such compounds for...
6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation  
Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically...
6716881 Carbanilides used as pesticides  
The present invention provides carbanilides of formula (I), wherein A, Q, R, X, Z and m are as defined herein. A plurality of processes for preparing these compounds is provided, along with...
6686381 Thiazole derivatives  
Compounds of formula I are provided as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 5 , n, m and A have the significance disclosed in the specification, and...
RE38330 Preventing and reversing advanced glycosylation endproducts  
The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, a composition is disclosed which comprises a...
6642180 Biphenyl-substituted cyclic ketoenols as pesticides  
The present invention relates to novel biphenyl-substituted cyclic ketoenols of the formula (I) in which W represents hydrogen, halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy,...
6610714 Non-nucleoside reverse transcriptase inhibitors  
Compounds of the formula I: where; R 1 is O, S; R 2 is an optionally substituted nitrogen-containing heterocycle, wherein the nitrogen is located at the 2 position relative to the (thio)urea...
6593327 Compounds and compositions as protease inhibitors  
The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and...
6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors  
Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R 1 and R 2 are as defined in the specification) or their...
6569874 Thiazoles as factor Xa inhibitors  
The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O...
6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor  
The present invention relates to thiazoles, oxazoles, imidazoles and pharmaceutical compositions comprising said compounds antagonizing the corticotropin releasing factor receptor (“CRF...
6498174 Substituted oxazoles and thiazoles derivatives as hPPAR&ggr and hPPARα activators  
The present invention discloses compounds of formula (I), and tautomeric forms, pharmaceutically acceptable salts, or solvates thereof. Preferably, the compounds of the invention are dual...
6458959 Anti-herpesvirus compounds and methods for identifying, making and using same  
This invention relates to methods for inhibiting herpes replication and for treating herpes infection in a mammal by inhibiting the herpes helicase-primase enzyme complex. This invention also...
Matches 1 - 50 out of 378 1 2 3 4 5 6 7 8 >